These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 36769182)
1. Olive AJ; Smith CM; Baer CE; Coers J; Sassetti CM Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769182 [TBL] [Abstract][Full Text] [Related]
2. Comparative transcriptomics reveals common and strain-specific responses of human macrophages to infection with Mycobacterium tuberculosis and Mycobacterium bovis BCG. Li P; Li Y; Wang CC; Xia LG Microb Pathog; 2024 Apr; 189():106593. PubMed ID: 38387847 [TBL] [Abstract][Full Text] [Related]
3. Natural and trained innate immunity against Mycobacterium tuberculosis. Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788 [TBL] [Abstract][Full Text] [Related]
4. Guanylate Binding Proteins Restrict Leishmania donovani Growth in Nonphagocytic Cells Independent of Parasitophorous Vacuolar Targeting. Haldar AK; Nigam U; Yamamoto M; Coers J; Goyal N mBio; 2020 Jul; 11(4):. PubMed ID: 32723921 [TBL] [Abstract][Full Text] [Related]
5. Stüve P; Minarrieta L; Erdmann H; Arnold-Schrauf C; Swallow M; Guderian M; Krull F; Hölscher A; Ghorbani P; Behrends J; Abraham WR; Hölscher C; Sparwasser TD; Berod L Front Immunol; 2018; 9():495. PubMed ID: 29675017 [No Abstract] [Full Text] [Related]
6. Guanylate binding proteins contained in the murine chromosome 3 are important to control mycobacterial infection. Marinho FV; Fahel JS; de Araujo ACVSC; Diniz LTS; Gomes MTR; Resende DP; Junqueira-Kipnis AP; Oliveira SC J Leukoc Biol; 2020 Oct; 108(4):1279-1291. PubMed ID: 32620042 [TBL] [Abstract][Full Text] [Related]
7. The glycosylated Rv1860 protein of Mycobacterium tuberculosis inhibits dendritic cell mediated TH1 and TH17 polarization of T cells and abrogates protective immunity conferred by BCG. Satchidanandam V; Kumar N; Jumani RS; Challu V; Elangovan S; Khan NA PLoS Pathog; 2014 Jun; 10(6):e1004176. PubMed ID: 24945624 [TBL] [Abstract][Full Text] [Related]
8. A defect in the synthesis of Interferon-γ by the T cells of Complement-C5 deficient mice leads to enhanced susceptibility for tuberculosis. Mashruwala MA; Smith AK; Lindsey DR; Moczygemba M; Wetsel RA; Klein JR; Actor JK; Jagannath C Tuberculosis (Edinb); 2011 Dec; 91 Suppl 1(Suppl 1):S82-9. PubMed ID: 22154007 [TBL] [Abstract][Full Text] [Related]
9. Mycobacterium tuberculosis PPE51 Inhibits Autophagy by Suppressing Toll-Like Receptor 2-Dependent Signaling. Strong EJ; Wang J; Ng TW; Porcelli SA; Lee S mBio; 2022 Jun; 13(3):e0297421. PubMed ID: 35467412 [TBL] [Abstract][Full Text] [Related]
10. EspA acts as a critical mediator of ESX1-dependent virulence in Mycobacterium tuberculosis by affecting bacterial cell wall integrity. Garces A; Atmakuri K; Chase MR; Woodworth JS; Krastins B; Rothchild AC; Ramsdell TL; Lopez MF; Behar SM; Sarracino DA; Fortune SM PLoS Pathog; 2010 Jun; 6(6):e1000957. PubMed ID: 20585630 [TBL] [Abstract][Full Text] [Related]
11. Lung Epithelial Signaling Mediates Early Vaccine-Induced CD4 Das S; Marin ND; Esaulova E; Ahmed M; Swain A; Rosa BA; Mitreva M; Rangel-Moreno J; Netea MG; Barreiro LB; Divangahi M; Artyomov MN; Kaushal D; Khader SA mBio; 2021 Aug; 12(4):e0146821. PubMed ID: 34253059 [TBL] [Abstract][Full Text] [Related]
12. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
13. The Mycobacterium tuberculosis glycoprotein Rv1016c protein inhibits dendritic cell maturation, and impairs Th1 /Th17 responses during mycobacteria infection. Su H; Peng B; Zhang Z; Liu Z; Zhang Z Mol Immunol; 2019 May; 109():58-70. PubMed ID: 30856410 [TBL] [Abstract][Full Text] [Related]
14. BCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosis. Tiwari S; Dutt TS; Chen B; Chen M; Kim J; Dai AZ; Lukose R; Shanley C; Fox A; Karger BR; Porcelli SA; Chan J; Podell BK; Obregon-Henao A; Orme IM; Jacobs WR; Henao-Tamayo M Vaccine; 2020 Oct; 38(45):7156-7165. PubMed ID: 32978002 [TBL] [Abstract][Full Text] [Related]
15. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells. Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of mycobacterial pathogenesis by host interferon-γ. Hop HT; Liao PC; Wu HY Cell Mol Life Sci; 2024 Sep; 81(1):380. PubMed ID: 39222120 [TBL] [Abstract][Full Text] [Related]
17. Cyclic di-AMP-mediated interaction between Mycobacterium tuberculosis ΔcnpB and macrophages implicates a novel strategy for improving BCG vaccination. Zhang Y; Yang J; Bai G Pathog Dis; 2018 Mar; 76(2):. PubMed ID: 29394352 [TBL] [Abstract][Full Text] [Related]
18. Deletion of BCG Hip1 protease enhances dendritic cell and CD4 T cell responses. Bizzell E; Sia JK; Quezada M; Enriquez A; Georgieva M; Rengarajan J J Leukoc Biol; 2018 Apr; 103(4):739-748. PubMed ID: 29345365 [TBL] [Abstract][Full Text] [Related]